Long Term Support for Pediatric Cancer Adult Survivors in Rhône-Alpes : Evaluation of Women Fertility.
NCT02665819 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101
Last updated 2018-02-20
Summary
PanCareLIFE Study is a cohort study of patients treated for cancer in childhood, and biological case-control study nested in the cohort (WP4) is coordinated by Erasmus MC-Sophia Children's Hospital in Holland.
Ensure optimal patient quality of life throughout his life is a priority for the research teams. PanCareLIFE Study also aims to identify the factors that predispose to impaired quality of life. It is in this light that will be offered to patients a quality of life questionnaires during the period of treatment and then periodically during long-term follow-up.
Conditions
- Pediatric Cancer
Interventions
- OTHER
-
Pediatric cancer women survivors
Women will incur a blood taking to obtain fertility indication.
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Saint Etienne
lead OTHER
Principal Investigators
-
BERGER Claire, MD · CHU SAINT-ETIENNE
-
Léonie CASAGRANDA, PhD · CHU SAINT-ETIENNE
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-23
- Primary Completion
- 2016-11-29
- Completion
- 2016-11-29
Countries
- France
Study Locations
More Related Trials
-
INTER-Regional COHORTE of Long Term Pancreatic Cancer Survivors
NCT04436679 ·Status: COMPLETED
-
Longitudinal, Prospective, French, Multicenter Cohort Study on Pancreatic Radiofrequency
NCT05871164 ·Status: RECRUITING
-
Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially Resectable
NCT02818907 ·Status: COMPLETED ·Phase: NA
-
Bonds Between Circulating Tumoral ADN (ctDNA) and the Development of Peritoneal Carcinomatosis for Patients Under PIPAC
NCT04766502 ·Status: COMPLETED ·Phase: NA
-
Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors
NCT01692873 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Stereotactic MR-guided Adaptive Radiotherapy for Locally Advanced Pancreatic Cancers
NCT07097064 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer
NCT00149578 ·Status: UNKNOWN ·Phase: PHASE2
-
PAncreas Borderline and Locally Advanced Snapshot Study
NCT05470738 ·Status: UNKNOWN
-
Quality of Life in Elderly Patients After Pancreatic Cancer Surgery
NCT06079229 ·Status: COMPLETED
-
Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma
NCT01360593 ·Status: COMPLETED ·Phase: PHASE2
-
Influence of Metastatic Sites on Survival Outcomes and Predictive Factors for Extended Survival in Metastatic Pancreatic Cancer a Retrospective Study
NCT07086352 ·Status: NOT_YET_RECRUITING
-
Observational Study of Quality of Live in Patients With Metastatic Pancreatic Cancer
NCT02342847 ·Status: COMPLETED
-
Evaluation of GEMCITEST in Patients With Pancreatic Cancer and Treated by Chemotherapy
NCT03599154 ·Status: COMPLETED
-
A Study of CP-4126 in Patients With Advanced Pancreatic Cancer
NCT00913198 ·Status: COMPLETED ·Phase: PHASE2
-
Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma
NCT05546853 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study on Quality of Life of Patients Receiving Nab-paclitaxel/Gemcitabine First Line Therapy, Including a Translational Program
NCT02691052 ·Status: COMPLETED
-
QUANTACT : Impact of Pangenomic QUANTitative Alterations in Cancer Therapy
NCT04762862 ·Status: ENROLLING_BY_INVITATION
-
Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer
NCT00651742 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
NCT01416662 ·Status: COMPLETED ·Phase: PHASE2
-
GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic Cancer
NCT05861336 ·Status: WITHDRAWN ·Phase: PHASE2
-
Prognostic and Predictive Markers of Treatment Response in Patients With PAC.
NCT05776342 ·Status: RECRUITING
-
PANCREATIC CANCER: DYNAMIC ASSESSMENT AT ALL STAGES OF TREATMENT
NCT05802485 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Lyon Real World Evidence in Metastatic NeuroEndocrine Tumours
NCT03863106 ·Status: UNKNOWN
-
Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients
NCT05380414 ·Status: RECRUITING ·Phase: NA
-
Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer
NCT02358161 ·Status: COMPLETED ·Phase: PHASE1/PHASE2